Vivocapital.com

Vivo Capital, a global healthcare investment firm, closed a new fund, at over $100m. Investors in The Vivo PANDA Fund include financial institutions, corporate entities, and family offices. The fund plans to invest the capital in innovative early-stage...

Vivo Capital said it raised $750 million for its eighth fund, according to a press release and a filing with the SEC. The firm said in the release Vivo Capital Fund VIII would invest in later stage pharmaceutical and medical device companies in the United...

Series A Sammamish, Washington-based OwnZones Media Network has gained $5.9 million in a Series A investment round. OwnZones leverages content aggregation and works with companies such as Reuters and The Guardian. The company debuted this past November...

Vivo Capital LLC bought a new position in shares of Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) during the first quarter, Holdings Channel reports. The institutional investor bought 1,599,592 shares of the company’s stock, valued at approximately $2...

Startup CEOs and investors with strong writing and teaching skills are welcome to post their ongoing stories and lessons learned. Contact me if interested. The JPMorgan Healthcare Conference By Marty Felsenthal It’s bigger than the Super Bowl, the...